Venetoclax for the treatment of translocation (11;14) AL amyloidosis
M Hasib Sidiqi(Curtin University), Prashant Kapoor, Rafaël Fonseca(Mayo Clinic in Arizona), David Dingli, Francis K. Buadi, Morie A. Gertz(Medical University of South Carolina), Mohammed A. Aljama(Juravinski Cancer Centre), Nelson Leung(WinnMed), Dragan Jevremović(Mayo Clinic in Arizona), Shaji Kumar(Mayo Clinic), Ronald S. Go(Mayo Clinic), Rahma Warsame, S. Vincent Rajkumar(WinnMed), Wilson I. Gonsalves(Mayo Clinic in Arizona), Taxiarchis Kourelis(Mayo Clinic in Arizona), Martha Q. Lacy(Mayo Clinic), Eli Muchtar(Mayo Clinic), Suzanne R. Hayman, Angela Dispenzieri(Mayo Clinic), Miriam Hobbs, Abdullah S. Al Saleh(Mayo Clinic)
Cited by 54
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k